Format

Send to

Choose Destination
Gastroenterology. 1994 Jan;106(1):42-8.

Association of p53 mutations with short survival in colorectal cancer.

Author information

1
Laboratoire de Génétique des Tumeurs, Institut Curie, Paris, France.

Abstract

BACKGROUND/AIMS:

Mutations in p53, a tumor suppressor gene located on chromosome 17p, are the most frequent genetic alterations found in human cancers. Increased intracellular concentration of p53, which is frequently but not systematically related to p53 mutation, has been proposed to be associated with poor prognosis in some tumor types. In colorectal cancer, this significance is still a matter of debate. To directly investigate the relationship between prognosis and p53 mutation, this study screened a series of 85 colorectal carcinomas for mutations in exons 5-8 of this gene.

METHODS:

Polymerase chain reaction-amplified products from tumor DNA were analyzed by denaturing gradient gel electrophoresis and direct DNA sequencing.

RESULTS:

Forty-four tumors were found to be mutated (52%). A strong correlation between the presence of a mutation and short survival was observed (P = 0.003). When tumors were classified according to their histological stage, a multivariate Cox model analysis showed that p53 mutation, rather than 17p allelic loss (previously proposed to convey prognostic information), was retained as the only independent prognostic factor (relative risk, 2.25; 95% confidence interval, 1.06-4.80; P < 0.029).

CONCLUSIONS:

Combined with staging, direct monitoring of p53 mutation improves prognostic accuracy for colorectal cancer.

PMID:
8276207
DOI:
10.1016/s0016-5085(94)94217-x
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center